Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Obesity
Pharma
AZ’s reported $10B offer for Rhythm fuels talks of a bidding war
Analysts at Jefferies, Leerink and William Blair suggest a bidding war could be brewing and that Rhythm is unlikely to settle for AZ’s current pitch.
Angus Liu
Nov 5, 2026 9:36am
Lilly lifts guidance on back of another lucrative GLP-1 quarter
Oct 29, 2026 3:31pm
Lilly, RevMed win key recommendations from European regulators
Oct 16, 2026 11:30am
How drugmakers can capitalize on the GLP-1 'consumer overlay'
Oct 7, 2026 10:00am
Lilly dives deep into Foundayo's cardio perks in T2D, obesity
Oct 1, 2026 11:38am
Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan
Sep 29, 2026 11:20am
